Interplay between Hepatitis C Virus and Redox Cell Signaling

Hepatitis C virus (HCV) infects approximately 3% of the world’s population. Currently licensed treatment of HCV chronic infection with pegylated-interferon-α and ribavirin, is not fully effective against all HCV genotypes and is associated to severe side effects. Thus, development of novel therapeut...

Full description

Bibliographic Details
Main Authors: Anna Teresa Palamara, Enrico Garaci, Anna Ruggieri, Rossella Sgarbanti, Lucia Nencioni, Simona Anticoli
Format: Article
Language:English
Published: MDPI AG 2013-02-01
Series:International Journal of Molecular Sciences
Subjects:
HCV
GSH
Akt
Online Access:http://www.mdpi.com/1422-0067/14/3/4705